Skip to main content
. 2022 Dec 16;11(12):1834. doi: 10.3390/antibiotics11121834

Figure 9.

Figure 9

Percentage of inhibition on EHVG-treated early (A,C,E) and mature biofilms (B,D,F) of Candida albicans ATCC 90,028 (A,B), C. albicans SC5314 (C,D) and C. glabrata ATCC 2001 (E,F) after 48 and 72 h, evaluated by MTT assay. Samples were treated with EHVG (1/4 and 1/2 for early biofilms, and 2× and 4× MIC for mature biofilms) and compared to untreated controls or the reference drugs Amphotericin B (Ampho B) and Fluconazole (Flu). (*) p < 0.05 compared to control. (#) p < 0.05 compared to Amphotericin B and (@) p <0.05 compared to fluconazole.